Plasma concentrations of Aβ40 and Aβ42 rise with age and are increased in people with mutations that cause early-onset Alzheimer's disease (AD). Amyloid beta (A'β) plasma levels were successfully used as an (endo)phenotype for gene discovery using a linkage approach in families with dominant forms of disease. Here, we searched for loci involved in Aβ plasma levels in a series of non-demented patients with hypertension in the Erasmus Rucphen Family study.Aβ40 andAβ42 levels were determined in 125 subjects with severe hypertension. All patients were genotyped with a 6,000 single nucleotide polymorphisms (SNPs) illumina array designed for linkage analysis.We conducted linkage analysis of plasma Aβ levels. None of the linkage analyses yielded genome-wide significant logarithm of odds (LOD) score over 3.3, but there was suggestive evidence for linkage (LOD>1.9) for two regions: 1q41 (LOD = 2.07) and 11q14.3 (LOD = 2.97), both for Aβ40. These regions were followed up with association analysis in the study subjects and in 320 subjects from a population-based cohort. For the Aβ40 region on chromosome 1, association of several SNPs was observed at the presenilin 2 gene (PSEN2) (p = 2.58 9 10-4 for rs6703170). On chromosome 11q14-21, we found some association (p = 3.1 9 10-3 for rs2514299). This linkage study of plasma concentrations ofAβ40 andAβ42 yielded two suggestive regions, of which one points toward a known locus for familial AD.

doi.org/10.1007/s00439-012-1210-2, hdl.handle.net/1765/59886
Human Genetics
Department of Neurology

Ibrahim-Verbaas, C., Zorkoltseva, I., Amin, N., Schuur, M., Coppus, A., Isaacs, A., … van Duijn, C. (2012). Linkage analysis for plasma amyloid beta levels in persons with hypertension implicates Aβ-40 levels to presenilin 2. Human Genetics, 131(12), 1869–1876. doi:10.1007/s00439-012-1210-2